Gotham Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.51M Sell
21,356
-6,421
-23% -$2.86M 0.06% 494
2025
Q1
$13.5M Sell
27,777
-2,334
-8% -$1.13M 0.11% 240
2024
Q4
$12.1M Buy
30,111
+2,978
+11% +$1.2M 0.12% 232
2024
Q3
$12.6M Buy
27,133
+2,422
+10% +$1.13M 0.13% 200
2024
Q2
$11.6M Buy
24,711
+6,393
+35% +$3M 0.15% 133
2024
Q1
$7.66M Buy
18,318
+1,225
+7% +$512K 0.12% 223
2023
Q4
$6.95M Buy
17,093
+4,992
+41% +$2.03M 0.13% 180
2023
Q3
$4.21M Buy
12,101
+648
+6% +$225K 0.09% 323
2023
Q2
$4.03M Sell
11,453
-522
-4% -$184K 0.09% 312
2023
Q1
$3.77M Sell
11,975
-13,765
-53% -$4.34M 0.09% 287
2022
Q4
$7.43M Sell
25,740
-11,867
-32% -$3.43M 0.21% 87
2022
Q3
$10.9M Buy
37,607
+8,791
+31% +$2.55M 0.33% 36
2022
Q2
$8.12M Buy
28,816
+1,336
+5% +$376K 0.26% 77
2022
Q1
$7.17M Buy
27,480
+4,725
+21% +$1.23M 0.22% 104
2021
Q4
$5M Buy
22,755
+2,488
+12% +$546K 0.16% 151
2021
Q3
$3.68M Sell
20,267
-16,038
-44% -$2.91M 0.15% 191
2021
Q2
$7.32M Buy
+36,305
New +$7.32M 0.31% 73
2020
Q4
Sell
-1,527
Closed -$416K 1104
2020
Q3
$416K Sell
1,527
-8
-0.5% -$2.18K 0.01% 771
2020
Q2
$446K Sell
1,535
-447
-23% -$130K 0.01% 768
2020
Q1
$472K Buy
1,982
+845
+74% +$201K 0.01% 731
2019
Q4
$249K Sell
1,137
-60,130
-98% -$13.2M ﹤0.01% 991
2019
Q3
$10.4M Buy
61,267
+59,466
+3,302% +$10.1M 0.18% 146
2019
Q2
$330K Buy
+1,801
New +$330K 0.01% 923
2018
Q2
Sell
-14,974
Closed -$2.44M 1051
2018
Q1
$2.44M Sell
14,974
-10
-0.1% -$1.63K 0.03% 471
2017
Q4
$2.25M Sell
14,984
-95,516
-86% -$14.3M 0.03% 479
2017
Q3
$16.8M Sell
110,500
-72,015
-39% -$10.9M 0.25% 118
2017
Q2
$23.5M Buy
+182,515
New +$23.5M 0.33% 86
2016
Q4
Sell
-66,716
Closed -$5.82M 1066
2016
Q3
$5.82M Sell
66,716
-41,940
-39% -$3.66M 0.08% 334
2016
Q2
$9.35M Buy
108,656
+103,610
+2,053% +$8.91M 0.11% 291
2016
Q1
$401K Sell
5,046
-6,747
-57% -$536K ﹤0.01% 797
2015
Q4
$1.48M Buy
+11,793
New +$1.48M 0.02% 546